Sebastien Hotte
Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, ON Canada · Juravinski Cancer Centre · Juravinski Cancer Centre, Hamilton, Ontario, Canada
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Sebastien Hotte as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 19:41 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT03385655 · Prostate Cancer Biomarker Enrichment and Treatment SelectionCanadian Cancer Trials Group · active not recruiting · Prostate Cancer · study chair
- Ph2NCT02788773 · Durvalumab With or Without Tremelimumab in Metastatic Castration Resistant Prostate CancerCanadian Cancer Trials Group · completed · Prostate Cancer · study chair
- Ph2NCT01678105 · A Phase II Study of Dovitinib in Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary GlandsOntario Clinical Oncology Group (OCOG) · completed · Recurrent Adenoid Cystic Carcinoma of the Salivary Glands, Metastatic Adenoid Cystic Carcinoma of the Salivary Glands, Salivary Gland Cancers · principal investigator
- Ph3NCT01578655 · Comparison of Cabazitaxel/Prednisone Alone or in Combination With Custirsen for 2nd Line Chemotherapy in Prostate CancerAchieve Life Sciences · completed · Prostate Cancer · principal investigator
- Ph2NCT01331083 · A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration Resistant Prostate CancerNCIC Clinical Trials Group · completed · Prostate Cancer · study chair
- Ph2NCT01260688 · Cediranib Maleate With or Without Dasatinib in Patients With HRPC-Resistant to Treatment With DocetaxelNational Cancer Institute (NCI) · completed · Hormone Refractory Prostate Cancer, Recurrent Prostate Cancer · principal investigator
- Ph1NCT01131234 · Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid TumorsNational Cancer Institute (NCI) · completed · Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma, Adult Anaplastic Oligodendroglioma · principal investigator
- Ph2NCT00886132 · A Study of Sunitinib in Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary GlandsUniversity Health Network, Toronto · completed · Adenoid Cystic Carcinoma, Salivary Gland Cancer · principal investigator
- Ph1NCT00390117 · AT7519M in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory Non-Hodgkin's LymphomaNCIC Clinical Trials Group · completed · Lymphoma, Unspecified Adult Solid Tumor, Protocol Specific · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-11 19:41 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Phase I Clinical Trials of New Anti-Cancer Targeted TherapiesU01CA070095 · NCI · JOHNS HOPKINS UNIVERSITY · PI Michael A Carducci · fiscal years 1995 to 2013Named on NCT01260688
- Princess Margaret Hospital Phase I ConsortiumU01CA132123 · NCI · UNIVERSITY HEALTH NETWORK · PI Lillian L Siu · fiscal years 2008 to 2013Named on NCT01260688, NCT01131234
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 19:41 UTC. The ranking covers the 200 most relevant of 60 PubMed records, and a shared surname and initials can bring in a namesake. All 60 on PubMed
- 248 citationsRCR 5.0
- Imatinib mesylate in patients with adenoid cystic cancers of the salivary glands expressing c-kit: a Princess Margaret Hospital phase II consortium study.J Clin Oncol · 2005216 citationsRCR 5.2
- 214 citationsRCR 5.3
- Randomized phase II study of docetaxel and prednisone with or without OGX-011 in patients with metastatic castration-resistant prostate cancer.J Clin Oncol · 2010188 citationsRCR 4.4
- A phase 1 study of mapatumumab (fully human monoclonal antibody to TRAIL-R1) in patients with advanced solid malignancies.Clin Cancer Res · 2008172 citationsRCR 3.7
- 129 citationsRCR 4.2
- Phase II study of Triapine in patients with metastatic renal cell carcinoma: a trial of the National Cancer Institute of Canada Clinical Trials Group (NCIC IND.161).Invest New Drugs · 2007121 citationsRCR 2.8
- 107 citationsRCR 3.4
- 103 citationsRCR 2.6
- 101 citationsRCR 3.2